Nelson, Van Denburg & Campbell Wealth Management Group, LLC Aligos Therapeutics, Inc. Transaction History
Nelson, Van Denburg & Campbell Wealth Management Group, LLC
- $2.63 Billion
- Q4 2024
A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Aligos Therapeutics, Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 80 shares of ALGS stock, worth $2,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80Holding current value
$2,581% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALGS
# of Institutions
2Shares Held
227KCall Options Held
0Put Options Held
0About Aligos Therapeutics, Inc.
- Ticker ALGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,717,000
- Market Cap $1.28B
- Description
- Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...